We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Immunodiagnostic Systems Showcases Next-Gen Immunoanalyzer at AACC

By LabMedica International staff writers
Posted on 31 Jul 2018
Immunodiagnostic Systems (Tyne & Wear, UK) showcased its next generation immunoanalyzer, the IDS-i10, at the AACC annual meeting and exhibition, the world’s largest scientific conference and tradeshow in the laboratory medicine field. More...
This year marked the 70th edition of the scientific meeting and clinical lab expo, hosted in McCormick Place, in Chicago, USA.

The exhibition provided a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields, including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. The tradeshow was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed in a variety of clinical areas through an educational experience, which could be tailored by selecting from a range of scientific sessions.

Immunodiagnostic Systems is a provider of in-vitro diagnostic solution to the clinical laboratory market. The company develops, manufactures and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty-testing menu and assay panels in complementary fields.

At AACC 2018, Immunodiagnostic Systems showcased its new IDS-i10 immunoanalyzer with faster testing capability and the capacity to connect to laboratory track systems. The instrument is designed to help medical professionals perform automated immunoassays more efficiently than ever. The company also discussed its automated and manual assay panels, with its experts available at the event to assist with queries from the attendees.

Related Links:
Immunodiagnostic Systems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Capillary testing on the Atellica analyzers supports the most common laboratory testing needs (Photo courtesy of Siemens Healthineers)

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.